Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin

S. G.M. Piccirillo, S. Dietz, B. Madhu, J. Griffiths, S. J. Price, V. P. Collins, C. Watts

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Background: Acquiring clinically annotated, spatially stratified tissue samples from human glioblastoma (GBM) is compromised by haemorrhage, brain shift and subjective identification of normal brain. We tested the use of 5-aminolevulinic acid (5-ALA) fluorescence to objective tissue sampling and to derive tumour-initiating cells (TICs) from mass and margin.Methods:The 5-ALA was administered to 30 GBM patients. Samples were taken from the non-fluorescent necrotic core, fluorescent tumour mass and non-fluorescent margin. We compared the efficiency of isolating TICs from these areas in 5-ALA versus control patients. HRMAS 1 H NMR was used to reveal metabolic alterations due to 5-ALA. We then characterised TICs for self-renewal in vitro and tumorigenicity in vivo.Results:The derivation of TICs was not compromised by 5-ALA and the metabolic profile was similar between tumours from 5-ALA patients and controls. The TICs from the fluorescent mass were self-renewing in vitro and tumour-forming in vivo, whereas TICs from non-fluorescent margin did not self-renew in vitro but did form tumours in vivo.Conclusion:Our data show that 5-ALA does not compromise the derivation of TICs. It also reveals that the margin contains TICs, which are phenotypically different from those isolated from the corresponding mass.

Original languageEnglish (US)
Pages (from-to)462-468
Number of pages7
JournalBritish Journal of Cancer
Volume107
Issue number3
DOIs
StatePublished - Jul 24 2012

Fingerprint

Neoplastic Stem Cells
Aminolevulinic Acid
Glioblastoma
Fluorescence
Population
Neoplasms
Metabolome
Intracranial Hemorrhages
Brain

Keywords

  • 5-ALA
  • human glioblastoma
  • tumour margin
  • tumour-initiating cells

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin. / Piccirillo, S. G.M.; Dietz, S.; Madhu, B.; Griffiths, J.; Price, S. J.; Collins, V. P.; Watts, C.

In: British Journal of Cancer, Vol. 107, No. 3, 24.07.2012, p. 462-468.

Research output: Contribution to journalArticle

@article{c65e4184d36246ef85bcf27a21c58e1c,
title = "Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin",
abstract = "Background: Acquiring clinically annotated, spatially stratified tissue samples from human glioblastoma (GBM) is compromised by haemorrhage, brain shift and subjective identification of normal brain. We tested the use of 5-aminolevulinic acid (5-ALA) fluorescence to objective tissue sampling and to derive tumour-initiating cells (TICs) from mass and margin.Methods:The 5-ALA was administered to 30 GBM patients. Samples were taken from the non-fluorescent necrotic core, fluorescent tumour mass and non-fluorescent margin. We compared the efficiency of isolating TICs from these areas in 5-ALA versus control patients. HRMAS 1 H NMR was used to reveal metabolic alterations due to 5-ALA. We then characterised TICs for self-renewal in vitro and tumorigenicity in vivo.Results:The derivation of TICs was not compromised by 5-ALA and the metabolic profile was similar between tumours from 5-ALA patients and controls. The TICs from the fluorescent mass were self-renewing in vitro and tumour-forming in vivo, whereas TICs from non-fluorescent margin did not self-renew in vitro but did form tumours in vivo.Conclusion:Our data show that 5-ALA does not compromise the derivation of TICs. It also reveals that the margin contains TICs, which are phenotypically different from those isolated from the corresponding mass.",
keywords = "5-ALA, human glioblastoma, tumour margin, tumour-initiating cells",
author = "Piccirillo, {S. G.M.} and S. Dietz and B. Madhu and J. Griffiths and Price, {S. J.} and Collins, {V. P.} and C. Watts",
year = "2012",
month = "7",
day = "24",
doi = "10.1038/bjc.2012.271",
language = "English (US)",
volume = "107",
pages = "462--468",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin

AU - Piccirillo, S. G.M.

AU - Dietz, S.

AU - Madhu, B.

AU - Griffiths, J.

AU - Price, S. J.

AU - Collins, V. P.

AU - Watts, C.

PY - 2012/7/24

Y1 - 2012/7/24

N2 - Background: Acquiring clinically annotated, spatially stratified tissue samples from human glioblastoma (GBM) is compromised by haemorrhage, brain shift and subjective identification of normal brain. We tested the use of 5-aminolevulinic acid (5-ALA) fluorescence to objective tissue sampling and to derive tumour-initiating cells (TICs) from mass and margin.Methods:The 5-ALA was administered to 30 GBM patients. Samples were taken from the non-fluorescent necrotic core, fluorescent tumour mass and non-fluorescent margin. We compared the efficiency of isolating TICs from these areas in 5-ALA versus control patients. HRMAS 1 H NMR was used to reveal metabolic alterations due to 5-ALA. We then characterised TICs for self-renewal in vitro and tumorigenicity in vivo.Results:The derivation of TICs was not compromised by 5-ALA and the metabolic profile was similar between tumours from 5-ALA patients and controls. The TICs from the fluorescent mass were self-renewing in vitro and tumour-forming in vivo, whereas TICs from non-fluorescent margin did not self-renew in vitro but did form tumours in vivo.Conclusion:Our data show that 5-ALA does not compromise the derivation of TICs. It also reveals that the margin contains TICs, which are phenotypically different from those isolated from the corresponding mass.

AB - Background: Acquiring clinically annotated, spatially stratified tissue samples from human glioblastoma (GBM) is compromised by haemorrhage, brain shift and subjective identification of normal brain. We tested the use of 5-aminolevulinic acid (5-ALA) fluorescence to objective tissue sampling and to derive tumour-initiating cells (TICs) from mass and margin.Methods:The 5-ALA was administered to 30 GBM patients. Samples were taken from the non-fluorescent necrotic core, fluorescent tumour mass and non-fluorescent margin. We compared the efficiency of isolating TICs from these areas in 5-ALA versus control patients. HRMAS 1 H NMR was used to reveal metabolic alterations due to 5-ALA. We then characterised TICs for self-renewal in vitro and tumorigenicity in vivo.Results:The derivation of TICs was not compromised by 5-ALA and the metabolic profile was similar between tumours from 5-ALA patients and controls. The TICs from the fluorescent mass were self-renewing in vitro and tumour-forming in vivo, whereas TICs from non-fluorescent margin did not self-renew in vitro but did form tumours in vivo.Conclusion:Our data show that 5-ALA does not compromise the derivation of TICs. It also reveals that the margin contains TICs, which are phenotypically different from those isolated from the corresponding mass.

KW - 5-ALA

KW - human glioblastoma

KW - tumour margin

KW - tumour-initiating cells

UR - http://www.scopus.com/inward/record.url?scp=84864332814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864332814&partnerID=8YFLogxK

U2 - 10.1038/bjc.2012.271

DO - 10.1038/bjc.2012.271

M3 - Article

VL - 107

SP - 462

EP - 468

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 3

ER -